Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Australas Psychiatry ; 31(6): 734-740, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37724416

RESUMEN

OBJECTIVES: We aimed to assess the degree of stigmatizing attitudes and psychological distress amongst Australian medical students in order to better understand factors that may impact help-seeking behaviours of students. We hypothesize that sociodemographic factors will not significantly predict stigmatizing attitudes, and increasing levels of psychological distress will be associated with increasing stigma. METHODS: A cross-sectional online survey was distributed to medical students at Western Australian universities and members of the Australian Medical Students' Association. Stigma was scored using the Mental Illness Clinicians' Attitudes (MICA-2) scale. Psychological distress was assessed using the Hospital Anxiety and Depression Scale (HADS). Participants provided information about gender, age, spirituality, financial hardship, treatment for mental illness, and experience in psychiatry. RESULTS: There were 598 responses. The mean (Standard Deviation) MICA-2 score was 36.8 (7.5) out of a maximum of 96, and the mean (SD) HADS depression score was 4.7 (3.7). The mean (SD) HADS anxiety score was 9.3 (4.4). Past or current treatment for a mental illness was associated with lower MICA-2 scores. There was no association between MICA-2 and HADS scores, or sociodemographic factors. CONCLUSIONS: Our results demonstrate relatively low MICA-2 scores and high HADS-A scores overall, with no association between HADS scores and stigma.


Asunto(s)
Trastornos Mentales , Estudiantes de Medicina , Humanos , Estudiantes de Medicina/psicología , Estudios Transversales , Australia , Actitud del Personal de Salud , Trastornos Mentales/psicología , Estigma Social , Encuestas y Cuestionarios
2.
Int J Equity Health ; 20(1): 149, 2021 06 29.
Artículo en Inglés | MEDLINE | ID: mdl-34187468

RESUMEN

BACKGROUND: Researching access to health services, and ways to improve equity, frequently requires researchers to recruit people facing social disadvantage. Recruitment can be challenging, and there is limited high quality evidence to guide researchers. This paper describes experiences of recruiting 1068 participants facing social disadvantage for a randomised controlled trial of prescription charges, and provides evidence on the advantages and disadvantages of recruitment methods. METHODS: Those living in areas of higher social deprivation, taking medicines for diabetes, taking anti-psychotic medicines, or with COPD were eligible to participate in the study. Several strategies were trialled to meet recruitment targets. We initially attempted to recruit participants in person, and then switched to a phone-based system, eventually utilising a market research company to deal with incoming calls. We used a range of strategies to publicise the study, including pamphlets in pharmacies and medical centres, media (especially local newspapers) and social media. RESULTS: Enrolling people on the phone was cheaper on average than recruiting in person, but as we refined our approach over time, the cost of the latter dropped significantly. In person recruitment had many advantages, such as enhancing our understanding of potential participants' concerns. Forty-nine percent of our participants are Maori, which we attribute to having Maori researchers on the team, recruiting in areas of high Maori population, team members' existing links with Maori health providers, and engaging and working with Maori providers. CONCLUSIONS: Recruiting people facing social disadvantage requires careful planning and flexible recruitment strategies. Support from organisations trusted by potential participants is essential. REGISTRATION: The Free Meds study is registered with the Australian and New Zealand Clinical Trials Registry ( ACTRN12618001486213 ).


Asunto(s)
Nativos de Hawái y Otras Islas del Pacífico , Determinantes Sociales de la Salud , Adulto , Anciano , Anciano de 80 o más Años , Australia , Femenino , Servicios de Salud , Humanos , Masculino , Persona de Mediana Edad , Nueva Zelanda , Selección de Paciente , Medios de Comunicación Sociales
3.
Cell Rep ; 14(10): 2289-300, 2016 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-26947080

RESUMEN

We report that p73 is expressed in multiciliated cells (MCCs), is required for MCC differentiation, and directly regulates transcriptional modulators of multiciliogenesis. Loss of ciliary biogenesis provides a unifying mechanism for many phenotypes observed in p73 knockout mice including hydrocephalus; hippocampal dysgenesis; sterility; and chronic inflammation/infection of lung, middle ear, and sinus. Through p73 and p63 ChIP-seq using murine tracheal cells, we identified over 100 putative p73 target genes that regulate MCC differentiation and homeostasis. We validated Foxj1, a transcriptional regulator of multiciliogenesis, and many other cilia-associated genes as direct target genes of p73 and p63. We show p73 and p63 are co-expressed in a subset of basal cells and suggest that p73 marks these cells for MCC differentiation. In summary, p73 is essential for MCC differentiation, functions as a critical regulator of a transcriptome required for MCC differentiation, and, like p63, has an essential role in development of tissues.


Asunto(s)
Cilios/metabolismo , Factores de Transcripción Forkhead/metabolismo , Redes Reguladoras de Genes , Pulmón/metabolismo , Proteína Tumoral p73/metabolismo , Animales , Bronquiolos/metabolismo , Bronquiolos/patología , Diferenciación Celular , Células Cultivadas , Cilios/patología , Células Epiteliales/citología , Células Epiteliales/metabolismo , Epitelio/metabolismo , Epitelio/patología , Femenino , Factores de Transcripción Forkhead/genética , Pulmón/citología , Pulmón/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Fosfoproteínas/deficiencia , Fosfoproteínas/genética , Fosfoproteínas/metabolismo , Interferencia de ARN , Análisis de Secuencia de ARN , Tráquea/metabolismo , Tráquea/patología , Transactivadores/deficiencia , Transactivadores/genética , Transactivadores/metabolismo , Transcriptoma , Proteína Tumoral p73/deficiencia , Proteína Tumoral p73/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA